161 related articles for article (PubMed ID: 35626301)
21. Fluorescence Confocal Microscopy for Ex Vivo Diagnosis of Conjunctival Tumors: A Pilot Study.
Iovieno A; Longo C; De Luca M; Piana S; Fontana L; Ragazzi M
Am J Ophthalmol; 2016 Aug; 168():207-216. PubMed ID: 27296488
[TBL] [Abstract][Full Text] [Related]
22. Basal cell carcinoma characterization using fusion ex vivo confocal microscopy: a promising change in conventional skin histopathology.
Pérez-Anker J; Ribero S; Yélamos O; García-Herrera A; Alos L; Alejo B; Combalia M; Moreno-Ramírez D; Malvehy J; Puig S
Br J Dermatol; 2020 Feb; 182(2):468-476. PubMed ID: 31220341
[TBL] [Abstract][Full Text] [Related]
23. Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy.
Siddiqui MM; Rais-Bahrami S; Truong H; Stamatakis L; Vourganti S; Nix J; Hoang AN; Walton-Diaz A; Shuch B; Weintraub M; Kruecker J; Amalou H; Turkbey B; Merino MJ; Choyke PL; Wood BJ; Pinto PA
Eur Urol; 2013 Nov; 64(5):713-719. PubMed ID: 23787357
[TBL] [Abstract][Full Text] [Related]
24. Ex vivo fluorescence confocal microscopy for intraoperative, real-time diagnosis of cutaneous inflammatory diseases: A preliminary study.
Bertoni L; Azzoni P; Reggiani C; Pisciotta A; Carnevale G; Chester J; Kaleci S; Reggiani Bonetti L; Cesinaro AM; Longo C; Pellacani G
Exp Dermatol; 2018 Oct; 27(10):1152-1159. PubMed ID: 30033578
[TBL] [Abstract][Full Text] [Related]
25. Ex vivo fluorescence confocal microscopy: the first application for real-time pathological examination of prostatic tissue.
Puliatti S; Bertoni L; Pirola GM; Azzoni P; Bevilacqua L; Eissa A; Elsherbiny A; Sighinolfi MC; Chester J; Kaleci S; Rocco B; Micali S; Bagni I; Bonetti LR; Maiorana A; Malvehy J; Longo C; Montironi R; Bianchi G; Pellacani G
BJU Int; 2019 Sep; 124(3):469-476. PubMed ID: 30908852
[TBL] [Abstract][Full Text] [Related]
26. Is magnetic resonance imaging-targeted biopsy a useful addition to systematic confirmatory biopsy in men on active surveillance for low-risk prostate cancer? A systematic review and meta-analysis.
Schoots IG; Nieboer D; Giganti F; Moore CM; Bangma CH; Roobol MJ
BJU Int; 2018 Dec; 122(6):946-958. PubMed ID: 29679430
[TBL] [Abstract][Full Text] [Related]
27. Contemporary Trends in Magnetic Resonance Imaging at the Time of Prostate Biopsy: Results from a Large Private Insurance Database.
Kim SP; Karnes RJ; Mwangi R; Van Houten H; Gross CP; Gershman B; Leapman MS; Shah ND
Eur Urol Focus; 2021 Jan; 7(1):86-94. PubMed ID: 31047904
[TBL] [Abstract][Full Text] [Related]
28. Intraoperative Digital Analysis of Ablation Margins (DAAM) by Fluorescent Confocal Microscopy to Improve Partial Prostate Gland Cryoablation Outcomes.
Selvaggio O; Falagario UG; Bruno SM; Recchia M; Sighinolfi MC; Sanguedolce F; Milillo P; Macarini L; Rastinehad AR; Sanchez-Salas R; Barret E; Lugnani F; Rocco B; Cormio L; Carrieri G
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503192
[TBL] [Abstract][Full Text] [Related]
29. MRI-targeted biopsy for detecting prostate cancer: have the guidelines changed our practices and our prostate cancer detection rate?
Baboudjian M; Bandelier Q; Gondran-Tellier B; Abdallah R; Michel F; Sichez PC; Di-Crocco E; Akiki A; Gaillet S; Delaporte V; Andre M; Daniel L; Karsenty G; Lechevallier E; Boissier R
Int Urol Nephrol; 2020 Apr; 52(4):611-618. PubMed ID: 31786702
[TBL] [Abstract][Full Text] [Related]
30. Additional value of magnetic resonance-targeted biopsies to standard transrectal ultrasound-guided biopsies for detection of clinically significant prostate cancer.
von Below C; Wassberg C; Norberg M; Tolf A; Kullberg J; Ladjevardi S; Häggman M; Bill Axelson A; Ahlström H
Scand J Urol; 2017 Apr; 51(2):107-113. PubMed ID: 28635568
[TBL] [Abstract][Full Text] [Related]
31. Digital Frozen Sections with Fluorescence Confocal Microscopy During Robot-assisted Radical Prostatectomy: Surgical Technique.
Rocco B; Sarchi L; Assumma S; Cimadamore A; Montironi R; Reggiani Bonetti L; Turri F; De Carne C; Puliatti S; Maiorana A; Pellacani G; Micali S; Bianchi G; Sighinolfi MC
Eur Urol; 2021 Dec; 80(6):724-729. PubMed ID: 33965288
[TBL] [Abstract][Full Text] [Related]
32. A Prospective Comparison of Selective Multiparametric Magnetic Resonance Imaging Fusion-Targeted and Systematic Transrectal Ultrasound-Guided Biopsies for Detecting Prostate Cancer in Men Undergoing Repeated Biopsies.
Boesen L; Nørgaard N; Løgager V; Balslev I; Thomsen HS
Urol Int; 2017; 99(4):384-391. PubMed ID: 28651247
[TBL] [Abstract][Full Text] [Related]
33. Accuracy of Ex-vivo Fluorescence Confocal Microscopy in Margin Assessment of Solid Tumors: A Systematic Review.
Au M; Almeida-Magana R; Al-Hammouri T; Haider A; Shaw G
J Histochem Cytochem; 2023 Dec; 71(12):661-674. PubMed ID: 37968920
[TBL] [Abstract][Full Text] [Related]
34. Perineural Invasion in Prostate Cancer Is More Frequently Detected by Multiparametric MRI Targeted Biopsy Compared With Standard Biopsy.
Gordetsky JB; Nix JW; Rais-Bahrami S
Am J Surg Pathol; 2016 Apr; 40(4):490-4. PubMed ID: 26523543
[TBL] [Abstract][Full Text] [Related]
35. Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers.
Hoeks CM; Schouten MG; Bomers JG; Hoogendoorn SP; Hulsbergen-van de Kaa CA; Hambrock T; Vergunst H; Sedelaar JP; Fütterer JJ; Barentsz JO
Eur Urol; 2012 Nov; 62(5):902-9. PubMed ID: 22325447
[TBL] [Abstract][Full Text] [Related]
36. Systematic and MRI-Cognitive Targeted Transperineal Prostate Biopsy Accuracy in Detecting Clinically Significant Prostate Cancer after Previous Negative Biopsy and Persisting Suspicion of Malignancy.
Vėželis A; Platkevičius G; Kinčius M; Gumbys L; Naruševičiūtė I; Briedienė R; Petroška D; Ulys A; Jankevičius F
Medicina (Kaunas); 2021 Jan; 57(1):. PubMed ID: 33435132
[No Abstract] [Full Text] [Related]
37. Combined mpMRI/US fusion targeted and concurrent standard biopsies in the detection of prostate cancer: a retrospective study.
Hubbard S; Wells SA; Olson K; Jarrard DF; Huang W
Am J Transl Res; 2021; 13(10):12107-12113. PubMed ID: 34786148
[TBL] [Abstract][Full Text] [Related]
38. Comparison between target magnetic resonance imaging (MRI) in-gantry and cognitively directed transperineal or transrectal-guided prostate biopsies for Prostate Imaging-Reporting and Data System (PI-RADS) 3-5 MRI lesions.
Yaxley AJ; Yaxley JW; Thangasamy IA; Ballard E; Pokorny MR
BJU Int; 2017 Nov; 120 Suppl 3():43-50. PubMed ID: 28749035
[TBL] [Abstract][Full Text] [Related]
39. MRI Screening and MRI/US Fusion-Guided Transperineal Biopsy in Detecting Prostate Cancer.
Yin H; Shao J; Song H; Ding W; Xu B; Cao H; Wang J
Technol Cancer Res Treat; 2021; 20():15330338211019418. PubMed ID: 34013808
[TBL] [Abstract][Full Text] [Related]
40. Prediction of Prostate Cancer Risk Among Men Undergoing Combined MRI-targeted and Systematic Biopsy Using Novel Pre-biopsy Nomograms That Incorporate MRI Findings.
Bjurlin MA; Rosenkrantz AB; Sarkar S; Lepor H; Huang WC; Huang R; Venkataraman R; Taneja SS
Urology; 2018 Feb; 112():112-120. PubMed ID: 29155186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
